Unlocking the Future of the Transcatheter Embolization And Occlusion Devices Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the transcatheter embolization and occlusion devices market?
The market for transcatheter embolization and occlusion devices has seen substantial growth recently. The market is projected to increase from $4.76 billion in 2024 to $5.28 billion in 2025, which equates to a compound annual growth rate (CAGR) of 10.9%. This growth during the historical period is due to factors such as a larger target demographic of patients, an increased frequency of minimally invasive vascular surgeries, a rise in vascular disease incidents, an escalation in chronic disease cases, and the demand for efficacious treatment alternatives.
What will be the transcatheter embolization and occlusion devices market size in the future?
The market for transcatheter embolization and occlusion devices is forecasted to experience swift expansion in the coming years, ballooning to a valuation of $7.87 billion in 2029, propelled by a compound annual growth rate (CAGR) of 10.5%. This growth trajectory for the forecast period is largely driven by escalated research and development activities, enhanced healthcare infrastructure, the rise of minimally invasive procedures, an ageing population, and increased workshops and public education efforts. The anticipated trends for this period involve technological progressions, improvements in imaging techniques, the incorporation of artificial intelligence and machine learning, continuous advancements in device design, and evolution in delivery systems.
Get your transcatheter embolization and occlusion devices market report here!
What main drivers are fueling expansion in the transcatheter embolization and occlusion devices market?
The increasing preference for procedures that are minimally invasive is set to fuel the expansion of the transcatheter embolization and occlusion devices market. These surgeries are characterized by their use of small incisions or natural body openings to diagnose and treat internal body organs or tissues, thus reducing harm to the patient. Transcatheter embolization and occlusion devices play a vital role in these procedures, as they offer numerous advantages such as decreased invasiveness, quicker recovery periods, targeted treatment, less discomfort, a lower chance of complications, and the possibility of being used in outpatient settings. For example, Intuitive Surgical Inc., a U.S.-based tech corporation focusing on minimally invasive healthcare products, reported in January 2023 that approximately 1,875,000 surgeries were conducted using Vinci surgical systems in 2022, marking an estimated 18% growth from roughly 1,594,000 surgeries conducted in 2021. Hence, the escalating preference for minimally invasive procedures is boosting the transcatheter embolization and occlusion devices market’s growth.
What key areas define the segmentation of the global transcatheter embolization and occlusion devices market?
The transcatheter embolization and occlusion devices market covered in this report is segmented –
1) By Type: Coil, Non-Coil
2) By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users
Subsegments:
1) By Coil: Bare Metal Coil, Surface Coated Coil, Detachable Coil
2) By Non-Coil: Gelatin Sponge, Liquid Embolic Agents, Spheres And Particles
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15944&type=smp
Which leading companies are shaping the growth of the transcatheter embolization and occlusion devices market?
Major companies operating in the transcatheter embolization and occlusion devices market are Pfizer Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., AtriCure Inc., Nordion Inc., Sirtex Medical Limited, Cordis Corporation, OpSens Inc., pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc.
What are the key trends shaping the future of the transcatheter embolization and occlusion devices market?
Key players in the transcatheter embolization and occlusion devices market focus on creating state-of-the-art products with capabilities such as multi-catheter compatibility to better suit their consumers’ needs and strengthen their position in the market. Multi-catheter compatibility is a function that works well with various catheters in interventional procedures, providing medical professionals with greater versatility and effectivity in conducting transcatheter embolization and occlusion operations. For example, in April 2022, Boston Scientific, a medical products company based in the United States, obtained FDA approval for the EMBOLD Fibered Detachable Coil, specifically designed for embolization procedures in the peripheral vasculature. As a component of the interventional oncology portfolio, it aspires to mitigate or lower blood flow in specific vessels to treat issues like hemorrhaging, aneurysms, tumor reduction, and venous abnormalities. It incorporates multi-catheter compatibility and includes a nitinol delivery system to avoid kinks. This coil simplifies procedures, minimizes potential risks, and amplifies efficiency.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15944
What regions are contributing significantly to the growth of the transcatheter embolization and occlusion devices market?
North America was the largest region in the transcatheter embolization and occlusion devices market in 2024. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Tumor Embolization Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Chronic Venous Occlusions Treatment Global Market Report 2024
Uterine Fibroid Embolization Device Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
